Research study Program year 2023 Source: CMS Open Payments

Phase Iib Multi-Center, Randomised, Partial-Blind Parallel Cohort Stud

Research payments

$881,069

176 payments

Through program year 2023, $881,069 in research payments was reported against Phase Iib Multi-Center, Randomised, Partial-Blind Parallel Cohort Stud, across 176 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$54,173	18
2022	Research	$99,267	65
2021	Research	$716,352	90
2020	Research	$11,278	3

Breakdown

Who paid Research payments · program years 2020–2023

GlaxoSmithKline, LLC. $881,069 176 payments

Who received the money Research payments · program years 2020–2023

South Florida Veterans Affairs Organisation paid for research $215,208 22 payments
NYU School of Medicine Organisation paid for research $165,144 37 payments
University Of Southern California Organisation paid for research $106,259 20 payments
Mcguire Research Institute Organisation paid for research $83,605 13 payments
Atlanta Cent Gastroenterology Organisation paid for research $76,785 17 payments
University of Pittsburgh Physicians Organisation paid for research $59,222 10 payments
Science37 INC Organisation paid for research $29,317 1 payment
Einstein Healthcare Network Organisation paid for research $25,680 7 payments
The General Hospital Corp Organisation paid for research $24,715 8 payments
Tufts Medical Center Inc Organisation paid for research $21,425 5 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.